| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Cost-effectiveness in the treatment of schizophrenia
|
Knapp, MRJ
|
|
1996
|
11 |
3 |
p. 137-143
7 p.
|
article
|
| 2 |
Cost-utility in CNS drug trials
|
Ziegler, F
|
|
1996
|
11 |
3 |
p. 159-164
6 p.
|
article
|
| 3 |
Designing dementia treatment studies: Diagnosis, efficacy criteria, and duration
|
Spiegel, R
|
|
1996
|
11 |
3 |
p. 149-154
6 p.
|
article
|
| 4 |
Key considerations for long-term studies with anxiolytics
|
Placchi, M
|
|
1996
|
11 |
3 |
p. 144-148
5 p.
|
article
|
| 5 |
Long-term studies in depression — relapse, recurrence, and reliability of outcome measures: Discussion
|
Sitsen, JMA
|
|
1996
|
11 |
3 |
p. 120-122
3 p.
|
article
|
| 6 |
Long-term studies in depression — relapse versus remission. Long-term studies with antidepressants — methodological aspects for consideration
|
Pedersen, V
|
|
1996
|
11 |
3 |
p. 116-119
4 p.
|
article
|
| 7 |
Long-term studies of antipsychotic drugs in schizophrenia
|
Lewander, T
|
|
1996
|
11 |
3 |
p. 127-134
8 p.
|
article
|
| 8 |
Long-term studies of antipsychotic drugs in schizophrenia — discussion
|
Möller, HJ
|
|
1996
|
11 |
3 |
p. 135-136
2 p.
|
article
|
| 9 |
Measuring patient benefit in mental illness
|
Gudex, C
|
|
1996
|
11 |
3 |
p. 155-158
4 p.
|
article
|
| 10 |
Methodological approaches to the long-term study of antidepressants
|
Rouillon, F
|
|
1996
|
11 |
3 |
p. 109-115
7 p.
|
article
|
| 11 |
Quality of life measurements in major depression
|
Bech, P
|
|
1996
|
11 |
3 |
p. 123-126
4 p.
|
article
|
Journal description